Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
0.910
-0.110 (-10.78%)
Nov 4, 2024, 4:00 PM EST - Market closed
Company Description
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People’s Republic of China.
It operates Xiaobai Maimai App that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations.
The company also sells medical devices, such as defibrillators and anesthesia laryngoscope. In addition, it is involved in the provision of health treatment services.
The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021.
Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
Akso Health Group
Country | China |
Founded | 2013 |
Industry | Medical Distribution |
Sector | Healthcare |
Employees | 9 |
CEO | Yilin Wang |
Contact Details
Address: Qiantongyuan Building, Room 8201-4-4(A), 2nd Floor Qingdao China | |
Phone | 86 15 2100 54919 |
Website | ahgtop.com |
Stock Details
Ticker Symbol | AHG |
Exchange | NASDAQ |
Fiscal Year | April - March |
Reporting Currency | USD |
CIK Code | 0001702318 |
CUSIP Number | 98422P108 |
ISIN Number | US98422P1084 |
SIC Code | 7389 |
Key Executives
Name | Position |
---|---|
Yilin Wang | Chief Executive Officer and Chairwoman of the Board |
Rui Zhang | Chief Financial Officer |
Daisy Wang | Investor Relation Contact |
Ma Xiaoqin | Corporate Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Sep 30, 2024 | UPLOAD | Filing |
Jul 30, 2024 | 20-F | Annual and transition report of foreign private issuers |
Jun 24, 2024 | F-6 POS | Post-effective amendments for immediately effective filing |
Jun 14, 2024 | UPLOAD | Filing |
May 2, 2024 | 6-K | Report of foreign issuer |
Mar 26, 2024 | 6-K | Report of foreign issuer |
Mar 19, 2024 | UPLOAD | Filing |
Mar 8, 2024 | 6-K | Report of foreign issuer |
Mar 7, 2024 | 424B5 | Filing |
Feb 23, 2024 | F-3 | Filing |